Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of pantoprazole gastro-resistant tablets under fasting conditions
TCTR20190403001Phase 1Completed
- Sponsor
- Medica Innova
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pantoprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Medica Innova. Started Jun 2019; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on TCTR20190403001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190403001.